Wednesday, November 15, 2017
Print Current Session:
|
|
Wednesday
SESSION 30:
IMPORTANCE OF FOOT ARTERIES AND PERFUSION IN CLTI: HOW TO ASSESS AND TREAT; VALUE OF ANGIOSOMES; METHODS TO EVALUATE EFFECTIVENESS OF TREATMENT
|
|
SESSION 30 SCHEDULE | |
4:38 PM - 4:43 PM | Anatomical Variability And Pathology Of Foot Arteries: When And How To Treat And Results: Value Of Angiosomes: Is There A Role For Bypass |
Presenter(s):Roberto Ferraresi, MD / Marco G. Manzi, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
4:44 PM - 4:49 PM | DEBATE: The Angiosome Concept Has Little Value: Never Deny A Patient With CLTI A Revascularization For Limb Salvage Based On It |
Presenter(s):Frank E.G. Vermassen, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
4:50 PM - 4:55 PM | DEBATE: When Does The Angiosome Concept Make A Difference And When Not: What Explains Discordant Results And Opinions |
Presenter(s):Richard F. Neville, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
4:56 PM - 5:01 PM | When Does The Angiosome Concept Matter: With Open Surgery For Limb Salvage; For Endovascular Treatments For Limb Salvage: How Does Indocyanine Green Fluorescence Imaging (IGFI) Help |
Presenter(s):Maarit Venermo, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
5:02 PM - 5:07 PM | Effective Non-Invasive Treatment Of CLTI By The Art-Assist Sequential Compression Device: How Does It Work By Improving The Capillary Circulation: Indications And Results |
Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
5:08 PM - 5:13 PM | 3-Year Results Of The SPINACH Trial Show What Factors Are Important For Selecting Open Or Endovascular Treatments For CLTI |
Presenter(s):Nobuyoshi Azuma, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
5:14 PM - 5:19 PM | Treatment Strategy For CLTI Should Depend On The Degree Of Ischemia And The Extent Of The Gangrene: This May Explain Different Opinions On Angiosomes |
Presenter(s):Joseph L. Mills, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
NON-INVASIVE IMAGING | |
5:20 PM - 5:25 PM | Modalities To Determine The Adequacy Of Pedal Revascularization In CLTI |
Presenter(s):Krishna J. Rocha-Singh, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
5:26 PM - 5:31 PM | DZAM: A Software Based System For Assessing Foot Perfusion From Doppler Signals: How Does It Work And Advantages |
Presenter(s):Cynthia K. Shortell, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
5:32 PM - 5:37 PM | Value Of The Profusa Lumee Implantable O2 Microsensors And Indocyanine Green Angiography To Assess Foot Perfusion Before And After Treatment For CLTI |
Presenter(s):Miguel F. Montero-Baker, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
5:38 PM - 5:43 PM | 2D Perfusion Angiography To Assess The Effectiveness Of Treatments On Foot Perfusion: How To Do It And Quantitate Its Results |
Presenter(s):Jos C. van den Berg, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
5:44 PM - 5:49 PM | A New Medium To Small Vessel Embolic Device (From Shape Memory): First In Man Trial - The IMPEDE Trial |
Presenter(s):Andrew Holden, MBChB Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
5:50 PM - 5:58 PM | Panel Discussion End of Program E |
END OF SESSION 30 | |
previous | next |